Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/24/2020 Oct/27/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/22/2020 Oct/27/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Oct/20/2020 Oct/26/2020 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/14/2020 Oct/05/2020 0
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 Sep/09/2020 0
Ethyl 2-[(E)-[[1-[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazol-5-yl]cyclopropyl]-pyridin-2-ylmethylidene]amino]oxyacetate Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 Sep/09/2020 0
Bis(5-amidino-2-benzimidazolyl)methane ketone Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 Sep/09/2020 0
Metocurine Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 Sep/09/2020 0
MolPort-000-735-951 Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 Sep/09/2020 0
AZD1222 Potential treatment - clinical evidence Experimental Vaccine Jul/30/2020 Sep/14/2020 0